148 related articles for article (PubMed ID: 11399689)
21. Effects of theophylline on tolerance to the bronchoprotective actions of salmeterol in asthmatics in vivo.
Cheung D; Wever AM; de GOEIJ JA; de GRAAFF CS; Steen H; Sterk PJ
Am J Respir Crit Care Med; 1998 Sep; 158(3):792-6. PubMed ID: 9731006
[TBL] [Abstract][Full Text] [Related]
22. Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the homozygous glycine-16 beta(2)-adrenoceptor polymorphism.
Lipworth BJ; Dempsey OJ; Aziz I
Chest; 2000 Aug; 118(2):321-8. PubMed ID: 10936119
[TBL] [Abstract][Full Text] [Related]
23. A 1-year study of salmeterol powder on pulmonary function and hyperresponsiveness to methacholine.
Kemp JP; DeGraff AC; Pearlman DS; Wang Y; Arledge TE; Welch MB; O'Riordan TG; Herrle MR; Stahl EG
J Allergy Clin Immunol; 1999 Dec; 104(6):1189-97. PubMed ID: 10589000
[TBL] [Abstract][Full Text] [Related]
24. Protection against allergen-induced asthma by salmeterol.
Twentyman OP; Finnerty JP; Harris A; Palmer J; Holgate ST
Lancet; 1990 Dec; 336(8727):1338-42. PubMed ID: 1978163
[TBL] [Abstract][Full Text] [Related]
25. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
Yates DH; Worsdell M; Barnes PJ
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
[TBL] [Abstract][Full Text] [Related]
26. The effect of salmeterol on the early- and late-phase reaction to bronchial allergen and postchallenge variation in bronchial reactivity, blood eosinophils, serum eosinophil cationic protein, and serum eosinophil protein X.
Pedersen B; Dahl R; Larsen BB; Venge P
Allergy; 1993 Jul; 48(5):377-82. PubMed ID: 8103646
[TBL] [Abstract][Full Text] [Related]
27. Additive effects of salmeterol and fluticasone or theophylline in COPD.
Cazzola M; Di Lorenzo G; Di Perna F; Calderaro F; Testi R; Centanni S
Chest; 2000 Dec; 118(6):1576-81. PubMed ID: 11115442
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids.
Wilson AM; Dempsey OJ; Sims EJ; Lipworth BJ
Chest; 2001 Apr; 119(4):1021-6. PubMed ID: 11296164
[TBL] [Abstract][Full Text] [Related]
29. The protective effect of salbutamol inhaled using different devices on methacholine bronchoconstriction.
Giannini D; Di Franco A; Bacci E; Dente FL; Taccola M; Vagaggini B; Paggiaro P
Chest; 2000 May; 117(5):1319-23. PubMed ID: 10807817
[TBL] [Abstract][Full Text] [Related]
30. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA
Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544
[TBL] [Abstract][Full Text] [Related]
31. Effect of salmeterol on allergen-induced airway inflammation in mild allergic asthma.
Boulet LP; Chakir J; Milot J; Boutet M; Laviolette M
Clin Exp Allergy; 2001 Mar; 31(3):430-7. PubMed ID: 11260155
[TBL] [Abstract][Full Text] [Related]
32. Regular inhaled salbutamol : effect on airway responsiveness to methacholine and adenosine 5'-monophosphate and tolerance to bronchoprotection.
Jokic R; Swystun VA; Davis BE; Cockcroft DW
Chest; 2001 Feb; 119(2):370-5. PubMed ID: 11171711
[TBL] [Abstract][Full Text] [Related]
33. The contribution of the swallowed fraction of an inhaled dose of salmeterol to it systemic effects.
Bennett JA; Harrison TW; Tattersfield AE
Eur Respir J; 1999 Feb; 13(2):445-8. PubMed ID: 10065696
[TBL] [Abstract][Full Text] [Related]
34. Salmeterol does not compromise the bronchodilator response to albuterol during acute episodes of asthma.
Korosec M; Novak RD; Myers E; Skowronski M; McFadden ER
Am J Med; 1999 Sep; 107(3):209-13. PubMed ID: 10492312
[TBL] [Abstract][Full Text] [Related]
35. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
Baraniuk J; Murray JJ; Nathan RA; Berger WE; Johnson M; Edwards LD; Srebro S; Rickard KA
Chest; 1999 Sep; 116(3):625-32. PubMed ID: 10492263
[TBL] [Abstract][Full Text] [Related]
36. Salmeterol does not alter increased bronchial responsiveness caused by organic dust exposure.
Ek A; Palmberg L; Sundblad BM; Larsson K
Chest; 2005 Oct; 128(4):3038-47. PubMed ID: 16236984
[TBL] [Abstract][Full Text] [Related]
37. Tolerance to the bronchoprotective effect of salmeterol 12 hours after starting twice daily treatment.
Drotar DE; Davis EE; Cockcroft DW
Ann Allergy Asthma Immunol; 1998 Jan; 80(1):31-4. PubMed ID: 9475563
[TBL] [Abstract][Full Text] [Related]
38. Effect of inhaled salmeterol on sulfur dioxide-induced bronchoconstriction in asthmatic subjects.
Gong H; Linn WS; Shamoo DA; Anderson KR; Nugent CA; Clark KW; Lin AE
Chest; 1996 Nov; 110(5):1229-35. PubMed ID: 8915226
[TBL] [Abstract][Full Text] [Related]
39. Salmeterol: a novel, long-acting beta 2-agonist.
Meyer JM; Wenzel CL; Kradjan WA
Ann Pharmacother; 1993 Dec; 27(12):1478-87. PubMed ID: 7905757
[TBL] [Abstract][Full Text] [Related]
40. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
Aziz I; Hall IP; McFarlane LC; Lipworth BJ
J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
